Paper40293223
A Cyanobacteria-Derived RNA Aptamer Resensitizes Prostate Cancer to Hormone Therapy.
Cruz-Hernández CD and 8 others. Cancer Res, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. A Cyanobacteria-Derived RNA Aptamer Resensitizes Prostate Cancer to Hormone Therapy. Papers, record 40293223. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40293223
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aptamers, Nucleotide | Major topic |
| Prostatic Neoplasms, Castration-Resistant | Major topic |
| Synechococcus | Major topic |
| Prostatic Neoplasms | Major topic |
| Male | |
| Humans | |
| Animals | |
| Mice | |
| Nitriles | |
| Glutamine | |
| Xenograft Model Antitumor Assays | |
| Cell Line, Tumor | |
| Benzamides | |
| Androgen Receptor Antagonists | |
| Phenylthiohydantoin | |
| Drug Resistance, Neoplasm | |
| Cell Proliferation | |
| Receptors, Androgen | |
| Mice, Nude |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 CA233452 | NCI NIH HHS | United States | P01CA233452 | PubMed and NIH | NIH RePORTER |
| W81XWH-19-1-0388 | U.S. Department of Defense (DOD) | PubMed | PubMed | ||
| CA233452 | National Cancer Institute (NCI) | P01CA233452 | PubMed and NIH | NIH RePORTER |
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30085248 | A glutamine riboswitch is a key element for the regulation of glutamine synthetase in cyanobacteria. | Nucleic Acids Res | 2018 | https://conductscience.org/library/papers/30085248 | PubMed |
| 2 | 20196592 | Fluorescent indicator displacement assay for ligand-RNA interactions. | J Am Chem Soc | 2010 | https://conductscience.org/library/papers/20196592 | PubMed |
| 3 | 31216023 | Structure and ligand binding of the glutamine-II riboswitch. | Nucleic Acids Res | 2019 | https://conductscience.org/library/papers/31216023 | PubMed |
| 4 | 34981784 | Clinical development of metabolic inhibitors for oncology. | J Clin Invest | 2022 | https://conductscience.org/library/papers/34981784 | PubMed |
| 5 | 38230766 | Cancer statistics, 2024. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38230766 | PubMed |
| 6 | 18559517 | Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity. | Cancer Res | 2008 | https://conductscience.org/library/papers/18559517 | PubMed |
| 7 | 27911493 | RNA Secondary Structure Prediction. | Curr Protoc Nucleic Acid Chem | 2016 | https://conductscience.org/library/papers/27911493 | PubMed |
| 8 | 15272118 | Using an RNA secondary structure partition function to determine confidence in base pairs predicted by free energy minimization. | RNA | 2004 | https://conductscience.org/library/papers/15272118 | PubMed |
| 9 | 11313721 | Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive system. | Cell Death Differ | 2001 | https://conductscience.org/library/papers/11313721 | PubMed |
| 10 | 32580469 | New Frontiers in Prostate Cancer Treatment: Are We Ready for Drug Combinations with Novel Agents? | Cells | 2020 | https://conductscience.org/library/papers/32580469 | PubMed |
| 11 | 29317493 | Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism. | J Biol Chem | 2018 | https://conductscience.org/library/papers/29317493 | PubMed |
| 12 | 27973417 | Applications of High-Throughput Sequencing for In Vitro Selection and Characterization of Aptamers. | Pharmaceuticals (Basel) | 2016 | https://conductscience.org/library/papers/27973417 | PubMed |
| 13 | 29017058 | Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling. | Cancer Cell | 2017 | https://conductscience.org/library/papers/29017058 | PubMed |
| 14 | 27665601 | Automated RNA 3D Structure Prediction with RNAComposer. | Methods Mol Biol | 2016 | https://conductscience.org/library/papers/27665601 | PubMed |
| 15 | 7559506 | The glutamine hydrolysis function of human GMP synthetase. Identification of an essential active site cysteine. | J Biol Chem | 1995 | https://conductscience.org/library/papers/7559506 | PubMed |
| 16 | 9111031 | Increased production of extracellular glutamate by the mitochondrial glutaminase following neuronal death. | J Biol Chem | 1997 | https://conductscience.org/library/papers/9111031 | PubMed |
| 17 | 22539264 | Automated 3D structure composition for large RNAs. | Nucleic Acids Res | 2012 | https://conductscience.org/library/papers/22539264 | PubMed |
| 18 | 17627883 | SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands. | Biomol Eng | 2007 | https://conductscience.org/library/papers/17627883 | PubMed |
| 19 | 35046532 | Targeting glutamine metabolism network for the treatment of therapy-resistant prostate cancer. | Oncogene | 2022 | https://conductscience.org/library/papers/35046532 | PubMed |
| 20 | 21988835 | Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. | Mol Syst Biol | 2011 | https://conductscience.org/library/papers/21988835 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42786162 | RNA therapeutics: current status and future directions. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42786162 | PubMed |
| 42706252 | Nucleic acid aptamers: new methods for selection, target validation, molecular diagnostics and therapeutics. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42706252 | PubMed |
| 41234842 | Identification and validation of RAS signaling-related genes for prognostic prediction and immunological characterization in gastric cancer. | Transl Cancer Res | 2025 | https://conductscience.org/library/papers/41234842 | PubMed |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GEO | GSE232596 |
Source GEO
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40293223
GET https://conductscience.org/api/papers/v1/40293223/references?page=2